Insmed (INSM)
94.04
-1.63 (1.70%)
Upcoming Events
Latest Headlines
Insmed (INSM) PT Lowered to $213 at Morgan Stanley
October 21, 2026 8:22 AM - StreetInsider
Form 4 INSMED Inc For: Oct 19 Filed by: Koppikar Utpal
October 20, 2026 5:08 PM - SEC Filing
Form 4 INSMED Inc For: Oct 19 Filed by: Hudson Paul
October 20, 2026 5:08 PM - SEC Filing
Form 3 INSMED Inc For: Oct 19 Filed by: Koppikar Utpal
October 20, 2026 5:06 PM - SEC Filing
Form 3 INSMED Inc For: Oct 19 Filed by: Hudson Paul
October 20, 2026 5:03 PM - SEC Filing
Form 8-K INSMED Inc For: Oct 16
October 20, 2026 7:01 AM - SEC Filing
Insmed adds two independent directors with biopharma backgrounds
October 20, 2026 7:00 AM - StreetInsider
Insmed Appoints Two New Directors to Its Board
October 20, 2026 7:00 AM - PR NewsWire
Insmed (INSM) PT Lowered to $173 at Raymond James
October 20, 2026 6:35 AM - StreetInsider
Insmed launches lung disease drug Brinsupri in Japan
October 19, 2026 7:01 AM - StreetInsider
Insmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan
October 19, 2026 7:00 AM - PR NewsWire
Insmed presents four-study TPIP lung disease trial program at CHEST 2026
October 15, 2026 7:01 AM - StreetInsider
Insmed Features the Global Phase 3 PALM Clinical Development Program Evaluating Treprostinil Palmitil Inhalation Powder (TPIP) at CHEST 2026
October 15, 2026 7:00 AM - PR NewsWire
Insmed to share respiratory data at CHEST 2026 and IDWeek 2026
October 14, 2026 7:00 AM - StreetInsider
Insmed to Present New Data Across Its Respiratory Portfolio at CHEST 2026 and IDWeek 2026
October 14, 2026 7:00 AM - PR NewsWire
Truist Securitas's Biotechnology Earnings Preview: 'INSM, BBIO, NBIX Most Levered to the Print'
October 12, 2026 9:04 AM - StreetInsider
Insmed (INSM) PT Lowered to $207 at BofA Securities
October 12, 2026 6:16 AM - StreetInsider
Wolfe Research Downgrades Insmed (INSM) to Peerperform
October 12, 2026 5:11 AM - StreetInsider
UBS Reiterates Buy Rating on Insmed (INSM) Into Q3 Earnings
October 8, 2026 9:33 AM - StreetInsider
BMO Capital on Insmed (INSM): 'CFO Transition Less of a Concern w/ FY2026 Guidance Reaffirmed'
October 6, 2026 9:40 AM - StreetInsider
RBC Capital maintains Outperform rating on Insmed amid CFO change
October 5, 2026 12:21 PM - StreetInsider
Insmed stock falls as CFO Sara Bonstein to step down
October 5, 2026 11:06 AM - StreetInsider
Form 8-K INSMED Inc For: Oct 05
October 5, 2026 7:01 AM - SEC Filing
Insmed CFO Sara Bonstein to step down October 30
October 5, 2026 7:00 AM - StreetInsider
Insmed Announces CFO Transition
October 5, 2026 7:00 AM - PR NewsWire
Insmed (INSM) PT Lowered to $207 at Barclays
September 30, 2026 6:55 AM - StreetInsider
Goldman Sachs Assumes Insmed (INSM) at Buy
September 24, 2026 4:59 AM - StreetInsider
Mizuho on Insmed (INSM): 'seeing attractive risk/reward'
September 22, 2026 9:04 AM - StreetInsider
FDA grants priority review to Insmed's Arikayce for MAC lung disease
September 21, 2026 7:00 AM - StreetInsider
FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of MAC Lung Disease With PDUFA Target Action Date Set for January 28, 2027
September 21, 2026 7:00 AM - PR NewsWire
Insmed Expands Community Impact During Fifth Annual Global Day of Good
September 16, 2026 7:00 AM - PR NewsWire
Form 4 INSMED Inc For: Sep 09 Filed by: Brennan David R
September 11, 2026 4:05 PM - SEC Filing
Form 144 INSMED Inc Filed by: Brennan David R
September 10, 2026 10:23 AM - SEC Filing
Insmed to Present at September 2026 Investor Conferences
August 26, 2026 7:00 AM - PR NewsWire
Form 4 INSMED Inc For: Aug 17 Filed by: SHAROKY MELVIN MD
August 25, 2026 7:03 PM - SEC Filing
Insmed (INSM) PT Raised to $195 at Mizuho
August 24, 2026 3:37 PM - StreetInsider
Japan approves Insmed's Brinsupri for lung disease treatment
August 24, 2026 7:03 AM - StreetInsider
BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
August 24, 2026 7:00 AM - PR NewsWire
Form 4 INSMED Inc For: Aug 17 Filed by: SHAROKY MELVIN MD
August 19, 2026 4:10 PM - SEC Filing
Form 144 INSMED Inc Filed by: SHAROKY MELVIN MD
August 17, 2026 4:18 PM - SEC Filing
Form SCHEDULE 13G/A INSMED Inc Filed by: Darwin Global Management, Ltd.
August 14, 2026 5:04 PM - SEC Filing
Form 4 INSMED Inc For: Aug 10 Filed by: Adsett Roger
August 12, 2026 5:05 PM - SEC Filing
Form 144 INSMED Inc Filed by: Adsett Roger
August 10, 2026 5:43 PM - SEC Filing
Insmed (INSM) PT Lowered to $175 at JPMorgan
August 10, 2026 8:56 AM - StreetInsider
Insmed (INSM) PT Raised to $195 at Truist Securities
August 10, 2026 7:22 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Insmed (INSM)
August 10, 2026 6:40 AM - StreetInsider
Form 4 INSMED Inc For: Aug 06 Filed by: Flammer Martina M.D.
August 7, 2026 4:39 PM - SEC Filing
Insmed (INSM) PT Raised to $169 at Wells Fargo
August 7, 2026 8:20 AM - StreetInsider
Form 144 INSMED Inc Filed by: Flammer Martina M.D.
August 6, 2026 4:12 PM - SEC Filing
Form SCHEDULE 13G/A INSMED Inc Filed by: FMR LLC
August 6, 2026 10:31 AM - SEC Filing
Insmed (INSM) Tops Q2 EPS by 62c; offers guidance
August 6, 2026 7:16 AM - StreetInsider
Form 8-K INSMED Inc For: Aug 06
August 6, 2026 7:01 AM - SEC Filing
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
August 6, 2026 7:01 AM - PR NewsWire
Form 10-Q INSMED Inc For: Jun 30
August 6, 2026 7:00 AM - SEC Filing
Cantor Fitzgerald Reiterates Overweight Rating on Insmed (INSM) Ahead of Q2 Results
July 28, 2026 9:44 AM - StreetInsider
Form 4 INSMED Inc For: Jul 23 Filed by: Lewis William
July 24, 2026 5:02 PM - SEC Filing
Full Article List
